Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Creative Medical Technology Holdings, Inc. (CELZ)

0.512   -0.041 (-7.35%) 02-03 14:19
Open: 0.57 Pre. Close: 0.5526
High: 0.57 Low: 0.4975
Volume: 139,362 Market Cap: 7(M)

Technical analysis

as of: 2023-02-03 2:15:37 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.67     One year: 0.79
Support: Support1: 0.44    Support2: 0.36
Resistance: Resistance1: 0.57    Resistance2: 0.67
Pivot: 0.51
Moving Average: MA(5): 0.53     MA(20): 0.49
MA(100): 0.45     MA(250): 1.01
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 69.3     %D(3): 72.4
RSI: RSI(14): 58.5
52-week: High: 5.14  Low: 0.33
Average Vol(K): 3-Month: 188 (K)  10-Days: 92 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CELZ ] has closed below upper band by 42.3%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.56 - 0.56 0.56 - 0.57
Low: 0.51 - 0.52 0.52 - 0.52
Close: 0.54 - 0.54 0.54 - 0.55

Company Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Headline News

Thu, 03 Nov 2022
Creative Medical Technology Holdings Announces FDA Clearance ... - PR Newswire

Thu, 20 Oct 2022
Creative Medical Technology Holdings Develops AlloStem ... - PR Newswire

Mon, 26 Sep 2022
Creative Medical Technology Announces Peer Reviewed ... - PR Newswire

Thu, 28 Jul 2022
Creative Medical Technology Announces Positive Top-Line Results ... - PR Newswire

Mon, 18 Jul 2022
Is it Time to Dump Creative Medical Technology Holdings Inc (CELZ) Stock After it Is Up 15.87% in a Week? - InvestorsObserver

Thu, 14 Jul 2022

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 6 (M)
% Held by Insiders 1.231e+007 (%)
% Held by Institutions 2.3 (%)
Shares Short 113 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.16e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -5
Return on Assets (ttm) 662.4
Return on Equity (ttm) -27.2
Qtrly Rev. Growth 92750
Gross Profit (p.s.) 0
Sales Per Share -16.14
EBITDA (p.s.) 8274.42
Qtrly Earnings Growth -0.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.04
Price to Cash Flow -50.13

Stock Dividends

Dividend 0
Forward Dividend 46100
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.